International Journal of Molecular Sciences, 20(11), 2768
However, there is evidence of this theory in existing literature cited by the researchers in their paper, which indicates poor glycemic control is a significant risk factor for glaucoma development due to the resultant microvascular and neurodegenerative damage from chronic hyperglycemia. Finally, weight reduction could play a role in the protective effect of GLP-1 receptor agonists against glaucoma, as studies have linked attaining a lower BMI to decreased IOP
GLP-1s are overtaking other common treatments for diabetes, particularly among the commercially insured GLP-1s are reshaping treatment for T2D and causing shifts in treatment paradigms across multiple disease areas
Nikoo M, Radnia H, Farokhnia M, Mohammadi MR, Akhondzadeh S
There is a separate, chemically different variant called CJC-1295 with DAC that binds to albumin, a carrier protein in the blood, and stays in circulation for days
And we made the liposome because at that time that was the [00:10:00] best technology that existed in the pharmaceutical world
